People · Operator
Named in public records as an officer, director or promoter · active 2010–2020 · Biotechnology, Pharmaceuticals, Biotech / Pharma, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SutroVax, Inc. | — | Biotechnology | Series D+ | $205.9M | $4.5B | 2020 |
| Mirum Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $138.5M | $347.9M | 2020 |
| Imago BioSciences, Inc. | — | Biotech / Pharma | Series C | $137.5M | $2.7B | 2019 |
| Iterum Therapeutics Ltd | — | Biotechnology | Series C | $131.4M | $115.8M | 2015 |
| Precision Dermatology, Inc. | — | Other Health Care | Series C | $103.4M | $1.3B | 2012 |
| VentiRx Pharmaceuticals Inc. | — | Biotechnology | Series C | $96.9M | $614.4M | 2010 |
| Iterum Therapeutics Bermuda Ltd | — | Pharmaceuticals | Series C | $51.6M | $1.8B | 2020 |
Patrick J. Heron at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Patrick J. Heron on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Heron | 2 | 11 |
| James I. Healy | 2 | 7 |
| Ronald M. Hunt | 2 | 4 |
| Shahzad M. Malik | 2 | 3 |
| David M Kelly | 2 | 3 |
| Brenton K. Ahrens | 2 | 3 |
| Patrick M. Heron | 2 | 3 |
| Patrick N. Heron | 2 | 3 |
| Corey N. Fishman | 2 | 2 |
| Judith M. Matthews | 2 | 2 |
| Mark I. Chin | 2 | 2 |
| Louise M. Barrett | 2 | 2 |
| Michael M. Dunne | 2 | 2 |
| Ed Mathers | 1 | 11 |
| Jonathan Leff | 1 | 11 |
| Michael Grey | 1 | 10 |
| Patrick Enright | 1 | 10 |
| Tiba Aynechi | 1 | 9 |
| Peter Hirth | 1 | 7 |
| Kurt Von Emster | 1 | 6 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.